Chromosomal analyses of human giant diploid oocytes by next-generation sequencing
- PMID: 34262393
- PMCID: PMC8254173
- DOI: 10.1002/rmb2.12378
Chromosomal analyses of human giant diploid oocytes by next-generation sequencing
Abstract
Purpose: Although giant oocytes (GOs) having about twice cytoplasmic volume compared with general oocytes in mammals including the human are rarely recovered, it is thought that GOs have potentially chromosomal abnormalities. The aim of the present study was to assess chromosome numbers in chromosome-spindle complexes (CSCs) and polar bodies of human GOs by using micromanipulation for sampling and next-generation sequencing (NGS) for analyses of the chromosome numbers.
Methods: When recovered oocytes whose cytoplasm has lager than 140 µm or above, the oocytes were defined as GOs, and recovered GOs were vitrified. After warming, the CSCs, polar bodies, and enucleated cytoplasm were collected by micromanipulation from 3 GOs. The collected samples were analyzed by NGS.
Results: Chromosomal aneuploidy in the GOs was confirmed in all the three GOs. Comparing the CSCs with the chromosomes from polar bodies, the deletion and overlapping chromosome numbers were complementary in each GO.
Conclusions: The authors could collect the CSCs and the polar bodies from human GOs by micromanipulation, and then could analyze the chromosome numbers of the GOs by NGS method. As our data suggest that human GOs have chromosomal abnormalities, GOs should be excluded from clinical purpose as gamete sources for embryo transfer in the human.
Keywords: cell size; cytodiagnosis; high‐throughput nucleotide sequencing; micromanipulation; oocytes.
© 2021 The Authors. Reproductive Medicine and Biology published by John Wiley & Sons Australia, Ltd on behalf of Japan Society for Reproductive Medicine.
Conflict of interest statement
Conflict of interest: The authors declare no conflict of interest in association with this manuscript. Human rights statement and informed consent: The present study was approved by the institutional ethics review board of Yamashita Shonan Yume Clinic held in October 2015 (Reference number: YSYC‐07) and National Center for Global Health and Medicine Ethics Review Board held in February 2020 (Reference number: 3370). All patients signed an informed written consent form before entering the study, and they were informed that they could terminate their cooperation with us whenever they wanted without any consequences.
Figures



References
-
- Lehner A, Kaszas Z, Murber A, Rigo J, Urbancsek J, Fancsovits P. Giant oocytes in human in vitro fertilization treatments. Arch Gynecol Obstet. 2015;292(3):697‐703. - PubMed
-
- Machtinger R, Politch JA, Hornstein MD, Ginsburg ES, Racowsky C. A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome? Fertil Steril. 2011;95(2):573‐576. - PubMed
-
- Rosenbusch B, Schneider M, Gläser B, Brucker C. Cytogenetic analysis of giant oocytes and zygotes to assess their relevance for the development of digynic triploidy. Hum Reprod. 2002;17(9):2388‐2393. - PubMed
-
- Balakier H, Bouman D, Sojecki A, Librach C, Squire JA. Morphological and cytogenetic analysis of human giant oocytes and giant embryos. Hum Reprod. 2002;17(9):2394‐2401. - PubMed
-
- Rosenbusch B. The potential significance of binovular follicles and binucleate giant oocytes for the development of genetic abnormalities. J Genet. 2012;91(3):397‐404. - PubMed
LinkOut - more resources
Full Text Sources